Applications of CRISPR Genome Engineering in Cell Biology

Trends in Cell Biology

Volumn 26, Issue 11, 2016, Pages 875-888

  Wang, Fangyuan ^a   Qi, Lei S ^b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Stanford University   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

cell biology; CRISPR Cas9; CRISPRi a; gene editing; gene regulation

Indexed keywords

CRISPR ASSOCIATED PROTEIN; CRISPR ASSOCIATED PROTEIN 9; ENDONUCLEASE; UNCLASSIFIED DRUG; GUIDE RNA;

BIOENGINEERING; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CYTOLOGY; DNA REPAIR; EPIGENETICS; FUNCTIONAL GENOMICS; GENETIC REGULATION; GENOME EDITING; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA EDITING; ANIMAL; CRISPR CAS SYSTEM; GENETIC ENGINEERING; GENETIC EPIGENESIS; GENETICS; GENOME; HUMAN; METABOLISM; PROCEDURES;

ANIMALS; CELL BIOLOGY; CRISPR-CAS SYSTEMS; EPIGENESIS, GENETIC; GENETIC ENGINEERING; GENOME; HUMANS; RNA, GUIDE;

EID: 84994504451     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2016.08.004     Document Type: Review

References (124)

1. 1 Capecchi, M.R., Altering the genome by homologous recombination. Science 244 (1989), 1288–1292.
2. 2 Rudin, N., et al. Genetic and physical analysis of double-strand break repair and recombination in Saccharomyces cerevisiae. Genetics 122 (1989), 519–534.
3. 3 Bibikova, M., et al. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol. Cell Biol. 21 (2001), 289–297.
4. 4 Bibikova, M., et al. Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics 161 (2002), 1169–1175.
5. 5 Urnov, F.D., et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435 (2005), 646–651.
6. 6 Christian, M., et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186 (2010), 757–761.
7. 7 Gaj, T., et al. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 31 (2013), 397–405.
8. 8 Wolfe, S.A., et al. DNA recognition by Cys2His2 zinc finger proteins. Annu. Rev. Biophys. Biomol. Struct. 29 (2000), 183–212.
9. 9 Beerli, R.R., Barbas, C.F. 3rd, Engineering polydactyl zinc-finger transcription factors. Nat. Biotechnol. 20 (2002), 135–141.
10. 10 Konermann, S., et al. Optical control of mammalian endogenous transcription and epigenetic states. Nature 500 (2013), 472–476.
11. 11 Zhang, F., et al. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat. Biotechnol. 29 (2011), 149–153.
12. 12 Maeder, M.L., et al. CRISPR RNA-guided activation of endogenous human genes. Nat. Methods 10 (2013), 977–979.
13. 13 Wiedenheft, B., et al. RNA-guided genetic silencing systems in bacteria and archaea. Nature 482 (2012), 331–338.
14. 14 Marraffini, L.A., Sontheimer, E.J., CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat. Rev. Genet. 11 (2010), 181–190.
15. 15 Nakata, A., et al. Cloning of alkaline phosphatase isozyme gene (iap) of Escherichia coli. Gene 19 (1982), 313–319.
16. 16 Barrangou, R., et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 (2007), 1709–1712.
17. 17 Brouns, S.J., et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321 (2008), 960–964.
18. 18 Jinek, M., et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337 (2012), 816–821.
19. 19 Deltcheva, E., et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471 (2011), 602–607.
20. 20 Sapranauskas, R., et al. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic. Acids Res. 39 (2011), 9275–9282.
21. 21 Marraffini, L.A., Sontheimer, E.J., Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature 463 (2010), 568–571.
22. 22 Cong, L., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339 (2013), 819–823.
23. 23 Mali, P., et al. RNA-guided human genome engineering via Cas9. Science 339 (2013), 823–826.
24. 24 Jinek, M., et al. RNA-programmed genome editing in human cells. Elife, 2, 2013, e00471.
25. 25 Hwang, W.Y., et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 31 (2013), 227–229.
26. 26 Cho, S.W., et al. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 31 (2013), 230–232.
27. 27 Makarova, K.S., et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol. 13 (2015), 722–736.
28. 28 Chylinski, K., et al. Classification and evolution of type II CRISPR-Cas systems. Nucleic. Acids Res. 42 (2014), 6091–6105.
29. 29 Gasiunas, G., et al. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), E2579–E2586.
30. 30 Ran, F.A., et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520 (2015), 186–191.
31. 31 Zhang, Y., et al. Processing-independent CRISPR RNAs limit natural transformation in Neisseria meningitidis. Mol. Cell 50 (2013), 488–503.
32. 32 Mali, P., et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31 (2013), 833–838.
33. 33 Sampson, T.R., et al. A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 497 (2013), 254–257.
34. 34 Hirano, H., et al. Structure and engineering of Francisella novicida Cas9. Cell 164 (2016), 950–961.
35. 35 Hale, C.R., et al. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 139 (2009), 945–956.
36. 36 Hale, C.R., et al. Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs. Mol. Cell 45 (2012), 292–302.
37. 37 Zetsche, B., et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163 (2015), 759–771.
38. 38 Yamano, T., et al. Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 165 (2016), 949–962.
39. 39 Dong, D., et al. The crystal structure of Cpf1 in complex with CRISPR RNA. Nature 532 (2016), 522–526.
40. 40 Fonfara, I., et al. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 532 (2016), 517–521.
41. 41 Abudayyeh, O.O., et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 353, 2016, aaf5573.
42. 42 Ran, F.A., et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154 (2013), 1380–1389.
43. 43 Komor, A.C., et al. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533 (2016), 420–424.
44. 44 Qi, L.S., et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152 (2013), 1173–1183.
45. 45 Peters, J.M., et al. A comprehensive, CRISPR-based functional analysis of essential genes in bacteria. Cell 165 (2016), 1493–1506.
46. 46 Gilbert, L.A., et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154 (2013), 442–451.
47. 47 Gilbert, L.A., et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159 (2014), 647–661.
48. 48 Konermann, S., et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517 (2015), 583–588.
49. 49 Larson, M.H., et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 8 (2013), 2180–2196.
50. 50 Zhao, Y., et al. Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system. Sci. Rep., 4, 2014, 3943.
51. 51 Perez-Pinera, P., et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat. Methods 10 (2013), 973–976.
52. 52 Cheng, A.W., et al. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res. 23 (2013), 1163–1171.
53. 53 Tanenbaum, M.E., et al. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159 (2014), 635–646.
54. 54 Chavez, A., et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 12 (2015), 326–328.
55. 55 Chavez, A., et al. Comparison of Cas9 activators in multiple species. Nat. Methods 13 (2016), 563–567.
56. 56 Zalatan, J.G., et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 160 (2015), 339–350.
57. 57 Hilton, I.B., et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 33 (2015), 510–517.
58. 58 Kearns, N.A., et al. Functional annotation of native enhancers with a Cas9-histone demethylase fusion. Nat. Methods 12 (2015), 401–403.
59. 59 Thakore, P.I., et al. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat. Methods 12 (2015), 1143–1149.
60. 60 Vojta, A., et al. Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic. Acids Res. 44 (2016), 5615–5628.
61. 61 Kearns, N.A., et al. Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells. Development 141 (2014), 219–223.
62. 62 Shi, J., et al. Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat. Biotechnol. 33 (2015), 661–667.
63. 63 Korkmaz, G., et al. Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9. Nat. Biotechnol. 34 (2016), 192–198.
64. 64 Shalem, O., et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343 (2014), 84–87.
65. 65 Bernstein, B.E., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 (2006), 315–326.
66. 66 Zhou, Y., et al. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature 509 (2014), 487–491.
67. 67 Chen, S., et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160 (2015), 1246–1260.
68. 68 Parnas, O., et al. A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks. Cell 162 (2015), 675–686.
69. 69 Wong, A.S., et al. Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. Proc. Natl. Acad. Sci. U.S.A. 113 (2016), 2544–2549.
70. 70 Evers, B., et al. CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes. Nat. Biotechnol. 34 (2016), 631–633.
71. 71 Morgens, D.W., et al. Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes. Nat. Biotechnol. 34 (2016), 634–636.
72. 72 Lane, A.B., et al. Enzymatically generated CRISPR libraries for genome labeling and screening. Dev Cell 34 (2015), 373–378.
73. 73 Friedland, A.E., et al. Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat. Methods 10 (2013), 741–743.
74. 74 Bassett, A.R., et al. Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep. 4 (2013), 220–228.
75. 75 Jao, L.E., et al. Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 13904–13909.
76. 76 Chang, N., et al. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res. 23 (2013), 465–472.
77. 77 Li, W., et al. Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat. Biotechnol. 31 (2013), 684–686.
78. 78 Lv, Q., et al. Efficient generation of myostatin gene mutated rabbit by CRISPR/Cas9. Sci. Rep., 6, 2016, 25029.
79. 79 Yan, Q., et al. Generation of multi-gene knockout rabbits using the Cas9/gRNA system. Cell Regen. (Lond)., 3, 2014, 12.
80. 80 Wang, X., et al. Generation of gene-modified goats targeting MSTN and FGF5 via zygote injection of CRISPR/Cas9 system. Sci. Rep., 5, 2015, 13878.
81. 81 Crispo, M., et al. Efficient generation of myostatin knock-out sheep using CRISPR/Cas9 technology and microinjection into zygotes. PLoS ONE, 10, 2015, e0136690.
82. 82 Zou, Q., et al. Generation of gene-target dogs using CRISPR/Cas9 system. J. Mol. Cell Biol. 7 (2015), 580–583.
83. 83 Wang, K., et al. Efficient generation of myostatin mutations in pigs using the CRISPR/Cas9 System. Sci. Rep., 5, 2015, 16623.
84. 84 Niu, Y., et al. Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell 156 (2014), 836–843.
85. 85 Wang, H., et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153 (2013), 910–918.
86. 86 Yang, H., et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154 (2013), 1370–1379.
87. 87 Platt, R.J., et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159 (2014), 440–455.
88. 88 Chiou, S.H., et al. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing. Genes. Dev. 29 (2015), 1576–1585.
89. 89 Swiech, L., et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat. Biotechnol. 33 (2015), 102–106.
90. 90 Sanchez-Rivera, F.J., et al. Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Nature 516 (2014), 428–431.
91. 91 Xue, W., et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature 514 (2014), 380–384.
92. 92 Lanctot, C., et al. Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat. Rev. Genet. 8 (2007), 104–115.
93. 93 Chen, B., et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155 (2013), 1479–1491.
94. 94 Anton, T., et al. Visualization of specific DNA sequences in living mouse embryonic stem cells with a programmable fluorescent CRISPR/Cas system. Nucleus 5 (2014), 163–172.
95. 95 Ma, H., et al. Multicolor CRISPR labeling of chromosomal loci in human cells. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 3002–3007.
96. 96 Deng, W., et al. CASFISH: CRISPR/Cas9-mediated in situ labeling of genomic loci in fixed cells. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 11870–11875.
97. 97 Ratz, M., et al. CRISPR/Cas9-mediated endogenous protein tagging for RESOLFT super–resolution microscopy of living human cells. Sci. Rep., 5, 2015, 9592.
98. 98 Kamiyama, D., et al. Versatile protein tagging in cells with split fluorescent protein. Nat. Commun., 7, 2016, 11046.
99. 99 Nelles, D.A., et al. Programmable RNA tracking in live cells with CRISPR/Cas9. Cell 165 (2016), 488–496.
100. 100 McKenna, A., et al. Whole-organism lineage tracing by combinatorial and cumulative genome editing. Science, 353, 2016, aaf7907.
101. 101 Shipman, S.L., et al. Molecular recordings by directed CRISPR spacer acquisition. Science, 353, 2016, aaf1175.
102. 102 Maddalo, D., et al. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 516 (2014), 423–427.
103. 103 Choi, P.S., Meyerson, M., Targeted genomic rearrangements using CRISPR/Cas technology. Nat. Commun., 5, 2014, 3728.
104. 104 Hsu, P.D., et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31 (2013), 827–832.
105. 105 Fu, Y., et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31 (2013), 822–826.
106. 106 Crosetto, N., et al. Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nat. Methods 10 (2013), 361–365.
107. 107 Tsai, S.Q., et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33 (2015), 187–197.
108. 108 Guilinger, J.P., et al. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat. Biotechnol. 32 (2014), 577–582.
109. 109 Tsai, S.Q., et al. Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat. Biotechnol. 32 (2014), 569–576.
110. 110 Fu, Y., et al. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 32 (2014), 279–284.
111. 111 Davis, K.M., et al. Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat. Chem. Biol. 11 (2015), 316–318.
112. 112 Slaymaker, I.M., et al. Rationally engineered Cas9 nucleases with improved specificity. Science 351 (2016), 84–88.
113. 113 Kleinstiver, B.P., et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529 (2016), 490–495.
114. 114 Plevock, K.M., et al. Newly characterized region of CP190 associates with microtubules and mediates proper spindle morphology in Drosophila stem cells. PLoS ONE, 10, 2015, e0144174.
115. 115 Bhattacharjee, A., et al. Activity of Menkes Disease protein ATP7A is essential for redox balance in mitochondria. J. Biol. Chem. 291 (2016), 16644–16658.
116. 116 Popow, J., et al. FASTKD2 is an RNA-binding protein required for mitochondrial RNA processing and translation. RNA 21 (2015), 1873–1884.
117. 117 Claussnitzer, M., et al. FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 373 (2015), 895–907.
118. 118 Birsoy, K., et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162 (2015), 540–551.
119. 119 D'Osualdo, A., et al. Transcription factor ATF4 induces NLRP1 inflammasome expression during endoplasmic reticulum stress. PLoS ONE, 10, 2015, e0130635.
120. 120 Plumb, R., et al. A functional link between the co-translational protein translocation pathway and the UPR. Elife, 4, 2015, e07426.
121. 121 Schoborg, T., et al. An Asp-CaM complex is required for centrosome-pole cohesion and centrosome inheritance in neural stem cells. J. Cell Biol. 211 (2015), 987–998.
122. 122 Li, J., et al. Glycosylation inhibition reduces cholesterol accumulation in NPC1 protein-deficient cells. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 14876–14881.
123. 123 Fuchs, G., et al. Kinetic pathway of 40S ribosomal subunit recruitment to hepatitis C virus internal ribosome entry site. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 319–325.
124. 124 Virreira Winter, S., et al. Genome-wide CRISPR screen reveals novel host factors required for Staphylococcus aureus alpha-hemolysin-mediated toxicity. Sci. Rep., 6, 2016, 24242.